Compare BNL & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNL | BHC |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 2.5B |
| IPO Year | 2020 | N/A |
| Metric | BNL | BHC |
|---|---|---|
| Price | $17.60 | $6.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $19.86 | $8.67 |
| AVG Volume (30 Days) | 2.0M | ★ 2.8M |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | ★ 6.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.47 | ★ 0.97 |
| Revenue | $447,973,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $5.68 | $6.81 |
| Revenue Next Year | $7.27 | $4.11 |
| P/E Ratio | $37.67 | ★ $7.15 |
| Revenue Growth | 5.49 | ★ 5.86 |
| 52 Week Low | $13.96 | $4.25 |
| 52 Week High | $18.87 | $8.69 |
| Indicator | BNL | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 56.07 |
| Support Level | $17.24 | $6.66 |
| Resistance Level | $17.84 | $7.20 |
| Average True Range (ATR) | 0.35 | 0.31 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 28.47 | 61.71 |
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.